# High-dose Cyclophosphamide for Severe Refractory Crohn Disease

> **NCT01836289** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Crohn's Disease
- Crohn Disease

## Interventions

- **DRUG:** High-dose Cyclophosphamide

## Key facts

- **NCT ID:** NCT01836289
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Too difficult to recruit given new Crohn's medications approved
- **Last updated:** 2018-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836289, "High-dose Cyclophosphamide for Severe Refractory Crohn Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01836289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*